Protocol S1900K, "A Randomized Phase II Study of Tepotinib with or without Ramucirumab in Participants with MET Exon 14 Skipping Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Sub-Study)"

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Locations

Greeley Campus
Harmony Campus
Medical Center of the Rockies
Memorial Hospital Central
Memorial Hospital North
Poudre Valley Hospital
University of Colorado Hospital

Principal Investigator
Photograph of Tejas Patil

Tejas Patil

Study ID

Protocol Number: 24-0486

More information available at ClinicalTrials.gov: NCT06031688

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers